XRF Scientific Limited (AU:XRF)
ASX:XRF
Top Page
XRF Scientific Limited
(Sydney:XRF)
Select Model
Select Model
Rating:67Neutral
Price Target:
AU$2.00
▲(20.48% Upside)
Action:ReiteratedDate:12/11/25
XRF Scientific Limited's overall stock score reflects strong financial performance with efficient operations and a solid balance sheet. However, mixed technical indicators and moderate valuation suggest limited growth potential without new catalysts. The absence of earnings call insights and corporate events further limits the score.
Positive Factors
Balance Sheet Strength
A very low debt-to-equity ratio provides durable financial flexibility: it reduces refinancing risk, supports investment in service capability or inventory during downturns, and allows management to pursue growth or capital returns without stressing liquidity.
Negative Factors
Weakening Revenue Momentum
A negative revenue growth trend signals waning sales momentum or market share pressures. If sustained, it erodes operating leverage, limits reinvestment capacity, and can force tighter cost management that may constrain growth initiatives and long-term competitiveness.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
A very low debt-to-equity ratio provides durable financial flexibility: it reduces refinancing risk, supports investment in service capability or inventory during downturns, and allows management to pursue growth or capital returns without stressing liquidity.
Read all positive factors
XRF Scientific Limited (XRF) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$237.45M
Dividend Yield2.31%
Average Volume (3M)240.16K
Price to Earnings (P/E)13.9
Beta (1Y)0.89
Revenue Growth-1.09%
EPS Growth14.88%
CountryAU
EmployeesN/A
SectorBasic Materials
Sector Strength58
IndustryHardware, Equipment & Parts
Share Statistics
EPS (TTM)0.04
Shares Outstanding143,040,080
10 Day Avg. Volume163,831
30 Day Avg. Volume240,164
Financial Highlights & Ratios
PEG Ratio1.67
Price to Book (P/B)4.29
Price to Sales (P/S)4.34
P/FCF Ratio30.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$2.30Price Target Upside38.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.08
Revenue Forecast (FY)AU$64.20M
XRF Scientific Limited Business Overview & Revenue Model
Company Description
XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction material, and mining industries in Australia, Canada, and Europe. It operates through Capi...
How the Company Makes Money
XRF Scientific Limited makes money primarily by selling and supporting products and services used in mineral analysis and laboratory testing. Key revenue streams include: (1) Product sales—revenue from the distribution/sale of laboratory and minin...
XRF Scientific Limited Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
80
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.91M | 59.45M | 59.84M | 55.17M | 40.01M | 31.29M |
| Gross Profit | 30.13M | 28.79M | 26.27M | 22.00M | 16.46M | 12.89M |
| EBITDA | 16.78M | 15.63M | 15.32M | 13.22M | 9.44M | 8.05M |
| Net Income | 10.63M | 10.38M | 8.89M | 7.69M | 6.08M | 5.13M |
Balance Sheet | ||||||
| Total Assets | 70.03M | 72.79M | 68.23M | 65.55M | 55.56M | 48.37M |
| Cash, Cash Equivalents and Short-Term Investments | 12.07M | 12.23M | 12.05M | 10.40M | 6.65M | 5.26M |
| Total Debt | 3.23M | 4.41M | 3.38M | 4.31M | 3.51M | 1.44M |
| Total Liabilities | 8.67M | 12.62M | 12.69M | 15.97M | 12.21M | 9.27M |
| Stockholders Equity | 61.36M | 60.17M | 54.89M | 49.25M | 43.48M | 39.10M |
Cash Flow | ||||||
| Free Cash Flow | 10.17M | 8.39M | 6.45M | 7.63M | 2.63M | 3.86M |
| Operating Cash Flow | 12.10M | 10.14M | 8.09M | 8.42M | 3.15M | 4.51M |
| Investing Cash Flow | -1.77M | -2.21M | -1.64M | -782.43K | -1.11M | -652.62K |
| Financing Cash Flow | -6.40M | -7.75M | -4.80M | -3.88M | -648.95K | -2.24M |
XRF Scientific Limited Technical Analysis
Negative
1.66
Price Trends
1.89
Negative
1.94
Negative
1.99
Negative
Market Momentum
-0.06
Negative
37.88
Neutral
33.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:XRF, the sentiment is Negative. The current price of 1.66 is below the 20-day moving average (MA) of 1.72, below the 50-day MA of 1.89, and below the 200-day MA of 1.99, indicating a bearish trend. The MACD of -0.06 indicates Negative momentum. The RSI at 37.88 is Neutral, neither overbought nor oversold. The STOCH value of 33.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:XRF.
XRF Scientific Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | AU$237.45M | 13.92 | 17.50% | 2.31% | -1.09% | 14.88% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | AU$154.36M | 4.74 | 2.67% | ― | 46.74% | -47.98% | |
51 Neutral | AU$1.66B | -1.53 | -63.71% | ― | ― | 70.81% | |
48 Neutral | AU$238.11M | -58.52 | -4.01% | ― | ― | 72.45% | |
43 Neutral | AU$100.59M | -10.68 | -9.37% | ― | ― | ― | |
42 Neutral | AU$412.63M | -6.45 | -117.09% | ― | ― | -186.15% |
* Basic Materials Sector Average
AU:XRF
XRF Scientific Limited
1.66
-0.13
-7.26%
AU:MTM
Mt Monger Resources Ltd.
0.56
0.41
273.33%
AU:DTR
Dateline Resources Limited
0.46
0.45
4450.00%
AU:KAU
Kaiser Reef Ltd
0.26
0.09
54.55%
AU:GG8
Labyrinth Resources Limited
0.33
-0.15
-32.29%
AU:PTN
Kin Mining NL
0.07
-0.01
-15.00%
XRF Scientific Limited Corporate Events
XRF Scientific Seeks ASX Quotation for New Employee Incentive Shares
Mar 4, 2026
XRF Scientific Limited has applied for quotation on the ASX of 47,712 ordinary fully paid shares, with an issue date of 4 March 2026. The new securities have been issued under the company’s employee incentive scheme, indicating ongoing use o...
XRF Scientific Sets Up Direct Operation in India to Target Long-Term Growth
Jan 27, 2026
XRF Scientific will establish a new office in India, marking a strategic shift from a distributor-led model to a direct presence in what it views as a key long-term growth market driven by mining and industrial demand. The Indian operation, to beg...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.